European Pharmacopoeia

EU-Specific

European standards for medicines and pharmaceutical substances published by the Council of Europe.

Sources

1. EDQM, Council of Europe — European Pharmacopoeia: all you need to know edqm.eu accessed 23 September 2026

The European Pharmacopoeia “is the primary source of official quality standards for medicines and their ingredients in Europe”, and its standards “provide a legal and scientific basis for the quality control of a product throughout its life cycle”. The word to notice is legal. As laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation, these standards “are legally binding”, and “all producers of pharmaceuticals must therefore apply them in order to market their products in the signatory states of the Convention”. That puts Ph. Eur. in a different category from most standards a manufacturer meets: compliance is not a commercial preference but a condition of market access across the Convention’s signatories. Texts are adopted by the European Pharmacopoeia Commission, which decides by consensus.

Sourced to the body that runs it. This entry cites the institution’s own account of its remit, which is authoritative for what the thing is and how it is meant to work. Where the page states a legal basis, that instrument — not the summary — is what binds, and it is worth reading before relying on a summary in a regulatory filing.

Related terms

• DG Trade
• ECHA
• EDQM
• EFSA
• EMA
• EU Customs Single Window

From the AJG lexicon archive (July 2026).